The American Journal of Medicine
Volume 114, Issue 4 , Pages 283-287 , March 2003

Abnormal vitamin B6 status is associated with severity of symptoms in patients with rheumatoid arthritis

  • En-Pei I Chiang, PhD

      Affiliations

    • Vitamin Metabolism and Aging Laboratory (EIC, PJB, JS, MN), Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA
    • ,
  • Pamela J Bagley, PhD

      Affiliations

    • Vitamin Metabolism and Aging Laboratory (EIC, PJB, JS, MN), Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA
    • ,
  • Jacob Selhub, PhD

      Affiliations

    • Vitamin Metabolism and Aging Laboratory (EIC, PJB, JS, MN), Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA
    • ,
  • Marie Nadeau, MS

      Affiliations

    • Vitamin Metabolism and Aging Laboratory (EIC, PJB, JS, MN), Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA
    • ,
  • Ronenn Roubenoff, MD, MHS

      Affiliations

    • Nutrition, Exercise Physiology, and Sarcopenia Laboratory (RR), Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA
    • General Clinical Research Center (RR), New England Medical Center, Boston, Massachusetts, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Ronenn Roubenoff, MD, MHS, Nutrition, Exercise Physiology, and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, 711 Washington Street, Boston, Massachusetts 02111, USA

Received 16 January 2002 ,Revised 26 September 2002 ,Accepted 8 October 2002.

References 

  1. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85:307–310
  2. Sanderson CR, Davis RE, Bayliss CE. Serum pyridoxal in patients with rheumatoid arthritis. Ann Rheum Dis. 1976;35:177–180
  3. Roubenoff R, Roubenoff RA, Selhub J, et al.  Abnormal vitamin B6 status in rheumatoid cachexia. Arthritis Rheum. 1995;38:105–109
  4. Roubenoff R, Dellaripa P, Nadeau MR, et al.  Abnormal homocysteine metabolism in rheumatoid cachexia. Arthritis Rheum. 1997;40:718–722
  5. Selhub J, Miller JW. Regulation of plasma homocysteine concentration by nutrients and drugs. In:  Mato JM,  Caballero A editor. Methionine Metabolism: Molecular Mechanisms and Clinical Implications. Madrid, Spain: Consejo Superior de Investigaciones Cientificas; 1994;
  6. Bett I. Urinary tryptophan metabolism in rheumatoid arthritis and some other diseases. Ann Rheum Dis. 1962;25:556–562
  7. Flinn JH, Price JM, Yess N. Excretion of tryptophan metabolites by patients with rheumatoid arthritis. Arthritis Rheum. 1964;7:201–210
  8. McKusick AB, Sherwin RW, Jones LG. Urinary excretion of 4-pyridoxic acid in rheumatoid arthritis. Arthritis Rheum. 1964;7:636–653
  9. Bucker FE, Smith HG, Lakatos C. Tryptophan metabolism in rheumatoid neuropathies. Ann Rheum Dis. 1972;31:311–315
  10. Chiang E-P. Vitamin B6 Status and Homocysteine Metabolism in Patients with Rheumatoid Arthritis [PhD dissertation]. Boston, Massachusetts: Tufts University; 2000;
  11. Smolin LA, Crenshaw TD, Kurtycz D, Benevenga NJ. Homocyst(e)ine accumulation in pigs fed diets deficient in vitamin B-6: relationship to atherosclerosis. J Nutr. 1983;113:2022–2033
  12. Clarke R, Daly L, Robinson K, et al.  Hyperhomocysteinemia (an independent risk factor for vascular disease). N Engl J Med. 1991;324:1149–1155
  13. Stampfer MJ, Mailnow MR, Willett WC, et al.  A prospective study of plasma homocysteine and risk of myocardial infarction in U.S. physicians. JAMA. 1992;268:877–881
  14. McKully KS. Chemical pathology of homocysteine (atherogenesis). Ann Clin Lab Sci. 1993;23:477–493
  15. Robinson K, Mayer EL, Miller DP, et al.  Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation. 1995;92:2825–2830
  16. Selhub J, Jacques PF, Bostom AG, et al.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286–291
  17. Arnett FC, Edworthy SM, Bloch DA, et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324
  18. Barland P, Lipstein E. Selection and use of laboratory tests in the rheumatic diseases. Am J Med. 1996;100(Suppl):16S–23S
  19. Hochberg MC, Chang RW, Dwosh I, et al.  The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992;35:498–502
  20. Fries JF. The dimension of health outcomes (the Health Assessment Questionnaire). J Rheumatol. 1982;9:786–793
  21. Camp VM, Chipponi J, Faraj BA. Radioenzyme assay for direct measurement of plasma pyridoxal 5′-phosphate. Clin Chem. 1983;29:642–644
  22. Araki A, Sako Y. Detection of free and total homocysteine in human plasma by HPLC with fluorescence detection. J Chromatogr. 1987;422:43–52
  23. Friso S, Jacques PF, Wilson PW, et al.  Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation. 2001;103:2788–2791
  24. Lumeng L, Brashear RE, Li TK. Pyridoxal 5′-phosphate in plasma (source, protein-binding, and cellular transport). J Lab Clin Med. 1974;84:334–343
  25. European COMAC Group Robinson K, Arheart K, Refsum H, et al.  Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation. 1998;97:437–443
  26. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843
  27. Wallberg-Jonsson S, Johansson H, Ohman ML, Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol. 1999;26:2562–2571

☆ This project was supported by the U.S. Department of Agriculture under cooperative agreement no. 58-1950-9-001. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the U.S. Department of Agriculture. This study was also supported in part by grant RR-00054 from the National Center for Research Resources, for the General Clinical Research Center, New England Medical Center, and Tufts University School of Medicine, and by an Arthritis Foundation Dissertation Award.

PII: S0002-9343(02)01528-0

doi: 10.1016/S0002-9343(02)01528-0

The American Journal of Medicine
Volume 114, Issue 4 , Pages 283-287 , March 2003

Article Tools

* Image Usage & Resolution